Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-23
1996-08-27
Gibson, Sharon
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548130, C07D51304, A61K 31435
Patent
active
055501389
ABSTRACT:
(1) a compound represented by the following formula (I): ##STR1## wherein R represents a hydrocarbon group or heterocyclic group which may be substituted; the ring A represents a pyridine ring having a substituent or a thiazole ring which may be substituted; or a pharmaceutically acceptable salt thereof, and a method of its production, and
(2) an endothelin receptor antagonist, an cathepsin B inhibitor or a bone resorption suppressor having as an active ingredient a compound represented by the following formula (I'): ##STR2## wherein R has the same definition as in term (1); the ring A' represents a pyridine ring or thiazole ring which may be substituted; or a pharmaceutically acceptable salt thereof.
REFERENCES:
Biochemical Pharmacology, vol. 44, No. 6, Sep. 25, 1992, pp. 1201-1207.
Chemical Abstracts, vol. 114, No. 3, Jan. 21, 1991, p. 696, Abstract No. 23848u.
Fujisawa Yukio
Mizoguchi Junji
Momose Yu
Sohda Takashi
Terashita Zen-ichi
Gibson Sharon
Kilby Scalzo Catherine
Takeda Chemical Industries Ltd.
LandOfFree
Condensed thiadiazole derivative, method of its production, and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed thiadiazole derivative, method of its production, and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed thiadiazole derivative, method of its production, and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056384